Literature DB >> 16096887

Methylphenidate: use in daily practice.

Jacqueline G Hugtenburg1, Judith E Griekspoor, Ingrid De Boer, Eibert R Heerdink, Yung Hwo Tso, Antoine C G Egberts.   

Abstract

OBJECTIVE: With the aim of getting more insight into compliance of children using methylphenidate, we studied the day-to-day use of the drug. In addition, the efficacy and side effects of treatment, stopping, switching to other drugs and the use of additional psychoactive drugs in daily practice were studied.
METHOD: On the basis of pharmacy records, the use of methylphenidate by 52 children was studied. Two parameters for compliance were calculated. By means of a questionnaire, parents were asked about their children's compliance with the use of methylphenidate as well as about their experience with treatment. MAIN OUTCOME MEASURE: Compliance, use of methylphenidate in weekends and holidays, self-reported efficacy, side effects, stopping and switching to other drugs.
RESULTS: Depending on the parameter calculated, the percentage of children with a good compliance varied from 25 to 47%. About 65% of the children used less or no methylphenidate in the weekends and holidays. Sixty-five percent of the parents reported to pass over a dose once in a while. According to 61% of the parents (n = 28) the efficacy of methylphenidate was good or very good. Nine (33%) of 28 children stopped using methylphenidate. Seven children stopped using the drug because of side-effects or lack of efficacy. Seven children switched to other psychoactive drugs. Fifty-seven percent of all children used additional psychoactive drugs.
CONCLUSION: The percentage of children having a good compliance calculated on the basis of pharmacy records is rather low. This is partly the result of the decreased use of methylphenidate in the weekends and holidays.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16096887     DOI: 10.1007/s11096-004-2848-1

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  20 in total

1.  Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial.

Authors:  D Efron; F Jarman; M Barker
Journal:  Pediatrics       Date:  1997-10       Impact factor: 7.124

2.  Impact of dosage frequency on patient compliance.

Authors:  A H Paes; A Bakker; C J Soe-Agnie
Journal:  Diabetes Care       Date:  1997-10       Impact factor: 19.112

3.  Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation.

Authors:  R A Barkley; M B McMurray; C S Edelbrock; K Robbins
Journal:  Pediatrics       Date:  1990-08       Impact factor: 7.124

Review 4.  The assessment of refill compliance using pharmacy records: methods, validity, and applications.

Authors:  J F Steiner; A V Prochazka
Journal:  J Clin Epidemiol       Date:  1997-01       Impact factor: 6.437

5.  How often is medication taken as prescribed? A novel assessment technique.

Authors:  J A Cramer; R H Mattson; M L Prevey; R D Scheyer; V L Ouellette
Journal:  JAMA       Date:  1989-06-09       Impact factor: 56.272

Review 6.  The direct effects of compliance on health outcome.

Authors:  L H Epstein
Journal:  Health Psychol       Date:  1984       Impact factor: 4.267

7.  Measuring patient compliance in antihypertensive therapy--some methodological aspects.

Authors:  H Enlund
Journal:  J Clin Hosp Pharm       Date:  1982-03

8.  Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists.

Authors:  Daryl Efron; Harriet Hiscock; Jillian R Sewell; Noel E Cranswick; Alasdair L A Vance; Yvonne Tyl; Ernest S L Luk
Journal:  Pediatrics       Date:  2003-02       Impact factor: 7.124

Review 9.  Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement.

Authors:  James Swanson
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  A general method of compliance assessment using centralized pharmacy records. Description and validation.

Authors:  J F Steiner; T D Koepsell; S D Fihn; T S Inui
Journal:  Med Care       Date:  1988-08       Impact factor: 2.983

View more
  3 in total

Review 1.  Pharmacologic treatment of ADHD: road conditions in driving patients to successful outcomes.

Authors:  Michael J Manos
Journal:  Medscape J Med       Date:  2008-01-08

2.  European guidelines on managing adverse effects of medication for ADHD.

Authors:  J Graham; T Banaschewski; J Buitelaar; D Coghill; M Danckaerts; R W Dittmann; M Döpfner; R Hamilton; C Hollis; M Holtmann; M Hulpke-Wette; M Lecendreux; E Rosenthal; A Rothenberger; P Santosh; J Sergeant; E Simonoff; E Sonuga-Barke; I C K Wong; A Zuddas; H-C Steinhausen; E Taylor
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-11-03       Impact factor: 4.785

3.  What stops practitioners discussing medication breaks in children and adolescents with ADHD? Identifying barriers through theory-driven qualitative research.

Authors:  Kinda Ibrahim; Parastou Donyai
Journal:  Atten Defic Hyperact Disord       Date:  2018-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.